# Investigation of Drug-drug Interaction of Dabigatran and Ticagrelor

> **NCT01734772** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 48 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** dabigatran etexilate
- **DRUG:** dabigatran etexilate
- **DRUG:** ticagrelor
- **DRUG:** ticagrelor
- **DRUG:** ticagrelor
- **DRUG:** dabigatran etexilate

## Key facts

- **NCT ID:** NCT01734772
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2014-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01734772

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01734772, "Investigation of Drug-drug Interaction of Dabigatran and Ticagrelor". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01734772. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*